Global pharmaceutical company Pfizer (NYSE:PFE) reported Q4 CY2024 results , with sales up 21.9% year on year to $17.76 ...

Global pharmaceutical company Merck (NYSE:MRK) reported Q4 CY2024 results , with sales up 6.8% year on year to $15.62 billion ...

India's J B Chemicals & Pharmaceuticals reported a bigger third-quarter profit on Tuesday, helped by sustained domestic demand for its drugs for chronic and acute conditions.

Merck (MRK) delivered earnings and revenue surprises of 1.78% and 0.45%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Vertex Pharmaceuticals ( VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) drugs, and ...

Pfizer’s adjusted fourth-quarter profit of 63 cents a share beat the FactSet consensus estimate of 47 cents a share. Revenue rose to $17.76 billion from $14.57 billion, and beat the FactSet consensus ...

These sensational income stocks -- sporting an average yield of 6.15% -- can fatten investors' pocketbooks for a long time to ...

The NSE Nifty 50 ended 121.10 points or 0.52% down at 23,361.05 and the BSE Sensex closed 319.22 points or 0.41% down at ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

Ligand Pharmaceuticals stock is on the rise with optimistic analyst ratings and a plan for 20% annual revenue growth. Learn ...

For the fiscal year 2024–2025, the Sun Pharma Board of Directors announced an interim dividend of Rs. 10.50/-per equity share ...

President Donald Trump's steep tariffs on Canada, Mexico and China could worsen ex­ist­ing drug short­ages in the U.S. and raise healthcare costs for patients, some drug trade groups warn.  They also ...